Another study reported that NRP-1 was overexpressed in medulloblastoma (MB) and related to the undifferentiated status of MB and that an NRP-1 inhibitor (MR438) could stimulate the differentiation of MB stem-like cells. The gene discussed is NRP1; the disease is medulloblastoma.